Nevirapine (Viramune)
Overview
- A Clinical Overview of Nevirapine (Viramune) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Prescribing Information for Nevirapine (Viramune) (PDF) (June 2007)
From Boehringer Ingelheim - Drug Interactions: Nevirapine (February 2002)
From Project Inform
News
- FDA Public Health Advisory for Nevirapine (Viramune) (January 19, 2005)
From U.S. Food and Drug Administration - Nevirapine Misinformation: Will It Kill? (December 31, 2004)
From AIDS Treatment News - South Africa Drops Recommendation of Single-Dose Nevirapine Monotherapy for Pregnant Women (July 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug (October 15, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - St. John's Wort Found to Lower Nevirapine Levels (March 2, 2001)
From Canadian AIDS Treatment Information Exchange - Nevirapine Warning on Post-Exposure Prophylaxis (January 12, 2001)
In AIDS Treatment News, from AIDS Treatment News
For Pregnancy/Newborns
- Adding Viread + Emtriva to Single-Dose Viramune Cuts Resistance Risk for Pregnant Women (November 17, 2007)
In The Lancet - Six-Month Delay in Onset of Nevirapine-Based Antiretroviral Therapy Can Prevent Drug Resistance Following Single-Dose Nevirapine During Labor, Study Says (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Nevirapine Resistance May Persist in Some Pregnant Women, Study Finds (May 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Combination Therapy Might Be Better Choice Than Nevirapine Alone to Prevent Vertical HIV Transmission, Researchers Say (February 25, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - The Risk of NNRTI Resistance Following Perinatal Nevirapine and Ramifications for Subsequent Antiretroviral Therapy Success (January 2005)
Part of HIV JournalView's Top 10 Research Reports of 2004.
From The Body PRO - Nevirapine Misinformation: Will It Kill? (December 31, 2004)
From AIDS Treatment News - Questions and Answers About the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV (December 17, 2004)
The United States responds to concerns over the Ugandan HIVNET 012 study.
From U.S. National Institute of Allergy and Infectious Diseases - Project Inform Defends the Use of Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV (December 15, 2004)
To read PDF, click here
From Project Inform - Comments on Nevirapine Resistance, by Global Strategies for HIV Prevention (November/December 2004)
Global Strategies is an international nonprofit organization focused specifically on aiding women and children at risk for HIV.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Pediatric AIDS Foundation on Single-Dose Nevirapine (November/December 2004)
In GMHC Treatment Issues, from Gay Men's Health Crisis - Single-Dose Drugs May Be Effective, But They Can Jeopardize Long-Term Therapy (November/December 2004)
Recent studies bring potentially bad news for HIV drugs with long half-lives.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Single-Dose Theory: A Historical Overview of the Use of Nevirapine to Prevent Mother-to-Child HIV Transmission (November/December 2004)
Includes a critical analysis of the late-2004 controversy over the drug's use in pregnant women.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Time to Move On: More Questions About Single-Dose Nevirapine (November/December 2004)
Two studies cast doubt on the overall cost-effectiveness of this strategy.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Nevirapine During Labor and in the Neonate Significantly Improves Zidovudine Prophylaxis for the Prevention of Perinatal HIV Transmission: Results of PHPT-2 First Interim Analysis (July 12, 2002)
In The XIV International AIDS Conference, from The Body PRO
Clinical Management
Clinical Management
  |